drugset / Trial / NCT01887353
The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of ranolazine in the prevention of recurrent atrial fibrillation in post-cardioversion patients with heart failure and preserved ejection fraction.
Timeline
- Start
- 2013-06
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranolazine | Small molecule | 1000 mg | — |